Modulators of Orphan Nuclear Receptors for Treating Pancreatitis, Glioblastoma, Sarcopenia and Stroke
US-2025339445-A1 · Nov 6, 2025 · US
This page is not indexed by search engines while we improve data quality.
Amblard Franck patents
Amblard Franck is listed as an inventor on 36 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Amblard Franck |
| Total patents | 36 |
| First publication | Nov 10, 2015 |
| Latest publication | Nov 6, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Modulators of orphan nuclear receptors for NASH and other metabolic disorders
US-12318393-B2 · Jun 3, 2025 · US
Nucleosides and nucleotides analogs as antiviral agents
US-2025114389-A1 · Apr 10, 2025 · US
Peptidomimetics for the treatment of coronavirus and picorna virus infections
US-12268723-B2 · Apr 8, 2025 · US
Combined modalities for nucleosides and/or NADPH oxidase (NOX) inhibitors as myeloid-specific antiviral agents
US-12239655-B2 · Mar 4, 2025 · US
Modified nucleosides and nucleotides analogs as antiviral agents for corona and other viruses
US-2024238323-A1 · Jul 18, 2024 · US
Thionucleosides as antiviral agents
US-2024216413-A1 · Jul 4, 2024 · US
Antiviral Agents and Nucleoside Analogs for Treatment of Zika Virus
US-2024216414-A1 · Jul 4, 2024 · US
Antiviral agents and nucleoside analogs for treatment of Zika virus
US-11963972-B2 · Apr 23, 2024 · US
Peptidomimetics for the treatment of Norovirus infection
US-11859014-B2 · Jan 2, 2024 · US
Recent patents
Latest publications not already listed above.
Pyrrole compounds
US-2023390242-A1 · Dec 7, 2023 · US
Elimination of hepatitis b virus with antiviral agents
US-11629125-B2 · Apr 18, 2023 · US
Monomer and multimeric anti-hbv agents
US-2023056135-A1 · Feb 23, 2023 · US
Antiviral Agents and Nucleoside Analogs for Treatment of Zika Virus
US-2023000893-A1 · Jan 5, 2023 · US
Peptidomimetics for the treatment of coronavirus and picornavirus infections
US-2022273753-A1 · Sep 1, 2022 · US
Pyrrole compounds
US-2022071957-A1 · Mar 10, 2022 · US
Peptidomimetics for the treatment of coronavirus and picornavirus infections
US-11207370-B2 · Dec 28, 2021 · US
Peptidomimetics for the treatment of norovirus infection
US-2021395300-A1 · Dec 23, 2021 · US
Peptidomimetics for the treatment of norovirus infection
US-11021513-B2 · Jun 1, 2021 · US
Elimination of hepatitis b virus with antiviral agents
US-2021114981-A1 · Apr 22, 2021 · US
Modulators of orphan nuclear receptors for nash and other metabolic disorders
US-2021052603-A1 · Feb 25, 2021 · US
Peptidomimetics for the treatment of coronavirus and picornavirus infections
US-2021008150-A1 · Jan 14, 2021 · US
Pyrrole compounds
US-2020323821-A1 · Oct 15, 2020 · US
Elimination of hepatitis B virus with antiviral agents
US-10752584-B2 · Aug 25, 2020 · US
Peptidomimetics for the treatment of norovirus infection
US-2020071354-A1 · Mar 5, 2020 · US
Elimination of hepatitis b virus with antiviral agents
US-2019241514-A1 · Aug 8, 2019 · US
Nucleoside analogs for treatment of the flaviviridae family of viruses and cancer
US-10011629-B2 · Jul 3, 2018 · US
Potent and selective inhibitors of hepatitis C virus
US-9932326-B2 · Apr 3, 2018 · US
Potent and selective inhibitors of hepatitis C virus
US-9926295-B2 · Mar 27, 2018 · US
2',2'-dihalo nucleoside analogs for treatment of the flaviviridae family of viruses and cancer
US-2017334941-A1 · Nov 23, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Emory | 36 |
| Cocrystal Pharma Inc | 8 |
| Aligos Therapeutics Inc | 3 |
| Cocrystal Pharma Llc | 2 |
| Hadasit Med Res Service | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K45/06 | 33 |
| A61P31/14 | 24 |
| Y02A50/30 | 16 |
| A61P31/12 | 13 |
| A61K31/4025 | 12 |